The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients

Glioblastoma multiforme (GBM) remains one of the most devastating tumors, and patients have a median survival of 15 months despite aggressive local and systemic therapy, including maximal surgical resection, radiation therapy, and concomitant and adjuvant temozolomide. The purpose of antineoplastic...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Poulsen, Hans Skovgaard, Urup, Thomas, Michaelsen, Signe Regner, Staberg, Mikkel, Villingshøj, Mette, Lassen, Ulrik
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2014
Предметы:
Review
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4186574/
https://ncbi.nlm.nih.gov/pubmed/25298738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S39306
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы